Frost Ronald 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Aug 12, 2022

Form 4

Period: 2022-08-10

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock, No Par Value
2022-08-10$16.05/sh+20,000$321,000→ 35,144 total
Sale
Common Stock, No Par Value
2022-08-10$62.10/sh−20,000$1,242,000→ 15,144 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2022-08-10−20,000→ 0 total
Exercise: $16.05From: 2017-01-28Exp: 2023-01-28→ Common stock (20,000 underlying)

Holdings

Common Stock, No Par Value
(indirect: By 401(k))
16,284
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying)
9,681
Non-qualified stock options (right to buy)
Exercise: $28.20From: 2018-04-14Exp: 2024-04-14→ Common Stock (50,000 underlying)
50,000
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying)
30,000
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (8,094 underlying)
8,094
Non-qualified stock options (right to buy)
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (40,000 underlying)
40,000
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (16,722 underlying)
16,722

Footnotes (8)

[F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.05 to $62.24, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]Become exercisable in equal annual installments of 20% commencing 01/28/2017.
[F3]Become exercisable in equal annual installments of 25% commencing 03/19/2022.
[F4]Become exercisable in equal annual installments of 20% commencing 04/14/2018.
[F5]Become exercisable in equal annual installments of 20% commencing 03/02/2019.
[F6]Become exercisable in equal annual installments of 20% commencing 03/01/2020.
[F7]Become exercisable in equal annual installments of 25% commencing 02/26/2021.
[F8]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.

Documents

1 file